U.K. stomach cancer Dx startup hopes to raise $150K

07/15/2013 | Clinica (subscription required)

U.K.-based Oxford Micro Medical seeks to obtain $150,000 in outside capital, which it will use to further develop its NanoBreath device. The handheld device, which will integrate a mass spectrometry tool originally tailored for space exploration, is intended to offer a more cost-effective alternative to existing breath assays for detecting stomach cancer.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA